Envestnet Asset Management Inc Immuno Gen, Inc. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.46 - $29.95 $271,341 - $652,221	-21,777 Reduced 33.78%	42,695 $1.27 Million
Q3 2023 Nov 13, 2023	BUY	$14.09 - $19.87 $505,211 - $712,458	35,856 Added 125.3%	64,472 $1.02 Million
Q2 2023 Aug 04, 2023	BUY	$3.75 - $20.05 $107,310 - $573,750	28,616 New	28,616 $539,000
Q3 2022 Nov 10, 2022	SELL	$4.48 - $6.47 $59,059 - $85,294	-13,183 Reduced 23.58%	42,726 $204,000
Q2 2022 Aug 03, 2022	SELL	$3.15 - $5.76 $9,954 - $18,201	-3,160 Reduced 5.35%	55,909 $252,000
Q1 2022 May 04, 2022	SELL	$4.26 - $7.48 $23,873 - $41,917	-5,604 Reduced 8.67%	59,069 $281,000
Q4 2021 Feb 04, 2022	BUY	$4.75 - $7.5 $1,548 - $2,445	326 Added 0.51%	64,673 $480,000
Q3 2021 Oct 07, 2021	BUY	$5.02 - $6.59 $9,914 - $13,015	1,975 Added 3.17%	64,347 $365,000
Q2 2021 Aug 04, 2021	BUY	$5.79 - $8.6 $11,950 - $17,750	2,064 Added 3.42%	62,372 $411,000
Q1 2021 May 04, 2021	BUY	$6.5 - $10.53 $29,789 - $48,258	4,583 Added 8.22%	60,308 $488,000
Q4 2020 Feb 02, 2021	SELL	$3.7 - $7.66 $9,494 - $19,655	-2,566 Reduced 4.4%	55,725 $359,000
Q3 2020 Oct 09, 2020	BUY	$3.45 - $4.89 $4,181 - $5,926	1,212 Added 2.12%	58,291 $210,000
Q2 2020 Jul 08, 2020	SELL	$3.32 - $5.34 $16,473 - $26,497	-4,962 Reduced 8.0%	57,079 $263,000
Q1 2020 Apr 23, 2020	SELL	$2.12 - $6.8 $11,700 - $37,529	-5,519 Reduced 8.17%	62,041 $212,000
Q4 2019 Feb 11, 2020	SELL	$2.25 - $5.8 $4,036 - $10,405	-1,794 Reduced 2.59%	67,560 $345,000
Q3 2019 Oct 17, 2019	SELL	$2.22 - $3.39 $3,540 - $5,407	-1,595 Reduced 2.25%	69,354 $168,000
Q2 2019 Aug 02, 2019	BUY	$1.8 - $3.3 $14,022 - $25,707	7,790 Added 12.33%	70,949 $154,000
Q1 2019 May 10, 2019	BUY	$2.41 - $5.91 $30,537 - $74,885	12,671 Added 25.1%	63,159 $171,000
Q4 2018 Feb 13, 2019	BUY	$3.94 - $9.7 $198,922 - $489,733	50,488 New	50,488 $242,000
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $212,660 - $278,437	-24,728 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$9.52 - $12.15 $5,007 - $6,390	-526 Reduced 2.08%	24,728 $240,000
Q1 2018 May 09, 2018	SELL	$6.7 - $12.95 $47,107 - $91,051	-7,031 Reduced 21.78%	25,254 $265,000
Q4 2017 Feb 20, 2018	BUY	$5.07 - $7.92 $32,747 - $51,155	6,459 Added 25.01%	32,285 $207,000
Q3 2017 Nov 13, 2017	SELL	$5.4 - $8.47 $5,810 - $9,113	-1,076 Reduced 4.0%	25,826 $196,000
Q2 2017 Aug 14, 2017	BUY	N/A	26,902	26,902 $192,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account